Reuters logo
BRIEF-Corbus Pharma says cystic fibrosis study data to be reported by Q1 2017 end
March 9, 2017 / 12:16 PM / 9 months ago

BRIEF-Corbus Pharma says cystic fibrosis study data to be reported by Q1 2017 end

March 9 (Reuters) - Corbus Pharmaceuticals Holdings Inc :

* Corbus Pharmaceuticals reports 2016 financial results and provides 2017 business update

* Topline data for phase 2 cystic fibrosis study expected to be reported by end of Q1 2017

* Company has sufficient capital to fund its operations into Q4 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below